IP Library › Assignment 036283/0268
Patent Assignment
Reel/Frame 036283/0268

Change of Name

Recorded: 2015-08-05 Pages: 3
Assignor
N30 PHARMACEUTICALS, LLC
Executed: 2012-07-31
Assignee
N30 PHARMACEUTICALS, INC.
3122 STERLING CIRCLE, BOULDER, COLORADO, 80301
Covered Property (1)
Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors
Patent: 9,315,462 →
Application: 14/817,329 →
Publication: US 2015/0336897
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 5, 2015
From: SUN, XICHENG; QIU, JIAN; STOUT, ADAM
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 036283/0265 →
Change of Name Aug 5, 2015
From: N30 PHARMACEUTICALS, INC.
To: NIVALIS THERAPEUTICS, INC.
Reel/Frame 036283/0280 →
Assignment of Assignor's Interest Jul 13, 2018
From: ALPINE IMMUNE SCIENCES, INC.
To: LAUREL VENTURE CAPITAL LTD.
Reel/Frame 046341/0795 →
Assignment of Assignor's Interest Apr 4, 2019
From: LAUREL VENTURE CAPITAL LTD.
To: LAUREL THERAPEUTICS LTD.
Reel/Frame 048787/0883 →